Amyotrophic Lateral Sclerosis Treatment Market Analysis by Treatment (Stem Cell Transplant, Medication), by Distribution Channel (Hospitals, Retail Pharmacies) and by Region - Forecast to 2029

The global Amyotrophic Lateral Sclerosis (ALS) treatment market size is estimated to be USD 725.58 million in 2021 and is expected to witness a CAGR of 6.97% during the forecast period. Increasing geriatric population worldwide, rising awareness for ALS, and increase in incidence of ALS are some of the key factors expected to boost growth of the global market. Conversely, the high cost related with ALS treatment is expected to hinder the growth during the forecast period.

Global Amyotrophic Lateral Sclerosis Treatment Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Treatment

Based on treatment, the amyotrophic lateral sclerosis treatment market is segmented into stem cell therapies, medications, and others. In 2021, the medications segment was the highest revenue-grossing segment owing to approval of two major drugs including Rilutek (riluzole) and Radicava (edaravone) by the U.S. FDA. However, the stem cell therapies segment is expected to grow at a fastest CAGR during the forecast period. This can be attributed to the rising demand for advanced treatment alternatives and new approaches for the management of ALS.

By Distribution Channel

Based on distribution channel, the market is categorized into hospitals, retail pharmacies, and others. Hospitals segment was the highest revenue-generating segment in 2021 and is estimated to hold its position during the forecast period. This is attributed to requirement to visit the hospital frequently and even stay for a higher duration during treatment. The retail pharmacies segment is expected to grow at a lucrative CAGR during the forecast period.

Regional Insights

In 2021, North America was the highest revenue-generating region in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of a well-developed healthcare expenditure, favorable reimbursement policies, growing healthcare expenditure, and increasing demand for advanced therapies. The Asia Pacific is expected to grow at the fastest CAGR over the forecast period owing to the rising prevalence of ALS, increasing R&D investment, presence of a developing healthcare infrastructure, and unmet medical needs in this region.

Competitor Insights

Some of the key players in the amyotrophic lateral sclerosis treatment market are Otsuka Pharmaceutical Co., Ltd. (Japan); Biogen (U.S.); BrainStorm Therapeutics (U.S.); Mitsubishi Tanabe Pharma Corporation (Japan); AB Science (France); Corestem (South Korea); Biohaven Pharmaceutical (U.S.); F.Hoffmann-La Roche AG (Switzerland); Ionis Pharmaceuticals, Inc. (U.S.); and Sun Pharmaceutical (India). Leading companies pursue different strategies such as business expansion in developing markets, new product growth, and strategic alliances to achieve a competitive edge.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The amyotrophic lateral sclerosis treatment market report is categorized into the following segments and subsegments:

Amyotrophic Lateral Sclerosis Treatment Market, By Technology (Revenue, 2021-2029, USD Million)

  • Medication
  • Stem Cell Therapy
  • Others

Amyotrophic Lateral Sclerosis Treatment Market, By Distribution Channel (Revenue, 2021-2029, USD Million)

  • Hospitals
  • Retail Pharmacies
  • Others

Amyotrophic Lateral Sclerosis Treatment Market, By Region (Revenue, 2021-2029, USD Million)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Amyotrophic Lateral Sclerosis Treatment Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

 

Table of Contents: Amyotrophic Lateral Sclerosis Treatment Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction:Amyotrophic Lateral Sclerosis Treatment
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis:Amyotrophic Lateral Sclerosis Treatment Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Treatment
    1. Stem cell therapy
      1. Stem cell therapy Market Forecast, 2021-2029 (USD Million)
    2. Medication
      1. Medication Market Forecast, 2021-2029 (USD Million)
    3. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Distrubution channel
    1. Retail pharmacies
      1. Retail pharmacies Market Forecast, 2021-2029 (USD Million)
    2. Hospital pharmacies
      1. Hospital pharmacies Market Forecast, 2021-2029 (USD Million)
    3. Other
      1. Other Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North AmericaAmyotrophic Lateral Sclerosis Treatment Market
    1. North AmericaAmyotrophic Lateral Sclerosis Treatment Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
        2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
      2. S.Amyotrophic Lateral Sclerosis Treatment Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
          2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
        2. CanadaAmyotrophic Lateral Sclerosis Treatment Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
            2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
  1. EuropeAmyotrophic Lateral Sclerosis Treatment Market
    1. EuropeAmyotrophic Lateral Sclerosis Treatment Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
        2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
        3. Market Size and Forecast by Device, 2021-2029 (USD Million)
      2. GermanyAmyotrophic Lateral Sclerosis Treatment Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
          2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
        2. UKAmyotrophic Lateral Sclerosis Treatment Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
            2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
          2. FranceAmyotrophic Lateral Sclerosis Treatment Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
              2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
            2. SpainAmyotrophic Lateral Sclerosis Treatment Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
                2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
              2. ItalyAmyotrophic Lateral Sclerosis Treatment Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
                2. Rest of EuropeAmyotrophic Lateral Sclerosis Treatment Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
  1. Asia PacificAmyotrophic Lateral Sclerosis Treatment Market
    1. Asia PacificAmyotrophic Lateral Sclerosis Treatment Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
        2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
      2. JapanAmyotrophic Lateral Sclerosis Treatment Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
          2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
        2. ChinaAmyotrophic Lateral Sclerosis Treatment Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
            2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
          2. IndiaAmyotrophic Lateral Sclerosis Treatment Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
              2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
            2. South KoreaAmyotrophic Lateral Sclerosis Treatment Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
                2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
              2. AustraliaAmyotrophic Lateral Sclerosis Treatment Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
                2. Rest of Asia PacificAmyotrophic Lateral Sclerosis Treatment Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
  1. Latin AmericaAmyotrophic Lateral Sclerosis Treatment Market
    1. Latin AmericaAmyotrophic Lateral Sclerosis Treatment Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
        2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
      2. BrazilAmyotrophic Lateral Sclerosis Treatment Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
          2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
        2. MexicoAmyotrophic Lateral Sclerosis Treatment Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
            2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
          2. ArgentinaAmyotrophic Lateral Sclerosis Treatment Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
              2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
              3. Market Size and Forecast by Device, 2021-2029 (USD Million)
            2. Rest of Latin AmericaAmyotrophic Lateral Sclerosis Treatment Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
                2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
  1. MEAAmyotrophic Lateral Sclerosis Treatment Market
    1. MEAAmyotrophic Lateral Sclerosis Treatment Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
        2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
      2. GCCAmyotrophic Lateral Sclerosis Treatment Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
          2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
        2. South AfricaAmyotrophic Lateral Sclerosis Treatment Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
            2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
          2. Rest of MEAAmyotrophic Lateral Sclerosis Treatment Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Treatment, 2021-2029 (USD Million)
              2. Market Size and Forecast by Distrubution channel, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2020 & 2031
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. AbbVie (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. Amgen Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. Johnson & Johnson (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. Eli Lilly and Company (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. Pfizer, Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. Hoffmann-La Roche AG (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. Astrazeneca Plc (U.K.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. Bristol-Myers Squibb Co. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. Lupin Limited (India)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    10. GlaxoSmithKline Plc (U.K.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Development
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    16. Others Prominent Players
  3. Conclusion & Recommendations

Select License Type

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports